179 related articles for article (PubMed ID: 2144431)
41. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
Shapiro S; Kohn D; Miller B; Gershon H
Clin Exp Immunol; 1994 Jan; 95(1):181-90. PubMed ID: 8287603
[TBL] [Abstract][Full Text] [Related]
42. An immunoradiometric assay for erythrocyte complement (C3b) receptor activity applied to a pediatric population with connective tissue disease.
Buffone GJ; Leatherwood CM; Person DA; Brewer EJ
Clin Chem; 1983 Oct; 29(10):1720-3. PubMed ID: 6616816
[TBL] [Abstract][Full Text] [Related]
43. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
Gibson NC; Waxman FJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
[TBL] [Abstract][Full Text] [Related]
44. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
Iida K; Mornaghi R; Nussenzweig V
J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
[TBL] [Abstract][Full Text] [Related]
45. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
[TBL] [Abstract][Full Text] [Related]
46. CR1 deficiency in SLE: acquired or genetic?
Uko G; Dawkins RL; Kay P; Christiansen FT; Hollingsworth PN
Clin Exp Immunol; 1985 Nov; 62(2):329-36. PubMed ID: 2935336
[TBL] [Abstract][Full Text] [Related]
47. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
Freysdottir J; Sigfusson A
J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
[TBL] [Abstract][Full Text] [Related]
48. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
49. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function.
Nilsson B; Ekdahl KN; Svarvare M; Bjelle A; Nilsson UR
Clin Exp Immunol; 1990 Nov; 82(2):262-7. PubMed ID: 2146995
[TBL] [Abstract][Full Text] [Related]
50. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
[TBL] [Abstract][Full Text] [Related]
51. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
[TBL] [Abstract][Full Text] [Related]
52. A kinetic study of erythrocyte-DNA/anti-DNA immune complex association and dissociation reactions in systemic lupus erythematosus.
Meryhew NL; Westling PR; Eerdmans ME; Janecek EJ; Runquist OA
Biochim Biophys Acta; 1989 Jun; 991(3):470-6. PubMed ID: 2786431
[TBL] [Abstract][Full Text] [Related]
53. Interaction between immune complexes and C3b receptors on erythrocytes.
Yoshida K; Yukiyama Y; Miyamoto T
Clin Immunol Immunopathol; 1986 May; 39(2):213-21. PubMed ID: 2938857
[TBL] [Abstract][Full Text] [Related]
54. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
[TBL] [Abstract][Full Text] [Related]
55. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
Manzi S; Navratil JS; Ruffing MJ; Liu CC; Danchenko N; Nilson SE; Krishnaswami S; King DE; Kao AH; Ahearn JM
Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
[TBL] [Abstract][Full Text] [Related]
56. The human C3b receptor: function and role in human diseases.
Tausk F; Gigli I
J Invest Dermatol; 1990 Jun; 94(6 Suppl):141S-145S. PubMed ID: 2141047
[TBL] [Abstract][Full Text] [Related]
57. Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).
Madi N; Steiger G; Estreicher J; Schifferli JA
Clin Exp Immunol; 1991 Sep; 85(3):373-8. PubMed ID: 1893616
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
Yoon SH; Fearon DT
J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
[TBL] [Abstract][Full Text] [Related]
59. Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus.
Cook JM; Kazatchkine MD; Bourgeois P; Mignon F; Mery JP; Kahn MF
Clin Immunol Immunopathol; 1986 Jan; 38(1):135-8. PubMed ID: 2934195
[TBL] [Abstract][Full Text] [Related]
60. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]